Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.

Shailesh Mahesh AdvaniPragati Shailesh AdvaniDerek W BrownStacia M DeSantisKrittiya KorphaisarnHelena M VonVilleJan BresslerDavid S LopezJennifer S DavisCarrie R DanielAmir Mehrvarz SarshekehDejana BraithwaiteMichael D SwartzScott Kopetz

Published in: BMC cancer (2019)

Although no differences were found for CIMP-H prevalence across countries, further studies are needed to compare the influence of demographic, lifestyle and environmental factors in relation to the prevalence of CIMP across geographical regions.

Keyphrases

weight loss
risk factors
dna methylation
type diabetes
cardiovascular disease
physical activity
metabolic syndrome
case control